Top Tweets for #MarginalZoneLymphoma
🚨 UPDATE: The @US_FDA has approved a new therapy for #marginalzonelymphoma. The approval is based on results from a phase 2 clinical trial led by Dr. @LiaPalomba, a hematologist-oncologist at MSK.
“People with this type of lymphoma have desperately needed a treatment that has lasting effects without toxicity,” Dr. Palomba says. “Lisocabtagene maraleucel is a critical advance and the first CAR T therapy approved to treat marginal zone lymphoma when it has relapsed after at least two previous treatments.”
Read more: https://t.co/8U3ukmUoFu
Frontline mosunetuzumab-axgb led to high and durable deep response rates, showing an ORR of 77.8% and a CR rate of 64% for patients with #MarginalZoneLymphoma.
Read here: https://t.co/Bneh27MTRv
It's day 3 of #SOHO25!🩸
We're bringing you more of the latest #hematology updates, ranging from #MarginalZoneLymphoma, #LBCL, and more.
Stay tuned for all the updates here and catch up on yesterday's coverage: https://t.co/w0brQnWdP0
@SocietyofHemOnc
#MZL First-Line Therapy (NCCN 2025)
Non-elderly:
• Bendamustine-R, CHOP-R, CVP-R
• Rituximab alone (esp. splenic MZL)
Elderly/Infirm:
• Rituximab monotherapy
• ± Chlorambucil or Cyclophosphamide
Maintenance: Rituximab q8–12w × 2 yrs
#MarginalZoneLymphoma #Hematology #NCCN
#MarginalZoneLymphoma (MZL): An Indolent #NHL
Origin: Memory B-cells in marginal zone
3 Subtypes:
• Extranodal (MALT)
• Splenic MZL
• Nodal MZL
Diagnosis: Tumor biopsy + expert review
Tx: Often watch & wait; chemoimmunotherapy for high burden
#Lymphoma #Hematology #MZL
❓ What's new in indolent B-cell lymphoma?
🏃💨 Head over to BCT to read about the latest @US_FDA news and clinical trial updates in #follicularlymphoma and #marginalzonelymphoma.
➡️ https://t.co/CtyWMyGXtj
I know it is terrifying, but if you have a lump, get it checked. #WorldCancerDay #nonhodgkins #marginalzonelymphoma #survivor
Today is #WorldCancerDay. Please repost this video and help us let even more people know about the symptoms of lymphoma, the UK's most common blood cancer.
Find out more 👉 https://t.co/3QUk9QPUEY
#Lymphoma #BloodCancer #CancerAwareness #Cancer
Lenalidomide, rituximab, and ibrutinib was effective as a first-line therapy for patients with #FollicularLymphoma and #MarginalZoneLymphoma, according to a phase II study.
Learn more: https://t.co/3xyOPQUtJv
👏🏽👏🏽Congratulations @womeninlymphoma #SteeringCommitteeMember Kim Linton @OfficialUoM & #WiL supporters @SFBarringtonKCL @tobyeyre82 #RenataWalewska et al on the publication of guideline article on #MZL #MarginalZoneLymphoma #lymphoma #lymsm @BrJHaem
https://t.co/aiAh1pxPcN
👏🏽 Congratulations @chanyooncheah & #JohnSeymour on your published update #lymphoma #MZL #MarginalZoneLymphoma #lymsm
https://t.co/GQOjKNsr5y
In this issue of Haematologica, Arribas and colleagues present a model of secondary resistance to #PI3Kδ inhibitors in #marginalZoneLymphoma (MZL).
https://t.co/4lSUvMrSnP
#WiLingWednesdays session this Wednesday Nov 3 at 3pm (London) with Prof @c_thieblemont & Prof Dr
@MinnemaMonique #MarginalZoneLymphoma & #Waldenstroms
Registration here https://t.co/0hWcEmisU5
Thanks to @SnowdomeAU @BeiGeneGlobal @bmsnews
@JanssenAustralia
We send medicine all around the world via DHL & EMS.
#Ibrutinib #ibrutix140mg #ibrutix
#ibrutinib140mg #MantleCellLymphoma #ChronicLymphocyticLeukemia #WaldenströmMacroglobulinemia
#Waldenström #MarginalZoneLymphoma
#leukemia #lymphoma #kinaseinhibitor
#TGTherapeutics’ $TGTX highly potential pipeline, is poised to fire up the market in the year 2021
PDUFA date for umbralisib to treat
>R/R #MarginalZoneLymphoma (MZL) (Feb 15, 2021)
>R/R #FollicularLymphoma ((FL) (June 15, 2021)
Well positioned for 2021 https://t.co/g9erCfMyd3
#NordicNanovector's #Betalutin® Receives #PositiveOpinion for #OrphanDrug Designation from #EMA for #MarginalZoneLymphoma (#MZL) $NANO https://t.co/lXKtVvdwQC
#TGTherapeutics Initiates #RollingSubmission of #NewDrugApplication (#NDA) to U.S. Food and Drug Administration for #Umbralisib as a Treatment for Patients with Previously Treated #MarginalZoneLymphoma or #FollicularLymphoma $TGTX https://t.co/gLABgO2qrD
NEWS: Verastem Oncology will be presenting five posters at #LymphomaMyeloma2019 highlighting clinical data in #CLL, #SLL, and refractory #MarginalZoneLymphoma. https://t.co/XcZcSTaH90
Read more: https://t.co/rvhJczJFbl
#WednesdayWisdom #Lenalidomide #Rituximab #FollicularLymphoma #MarginalZoneLymphoma #Lymphoma #Hematology #Oncology #FL #MZL
The @US_FDA approved lenalidomide (revlimid) in combination with a rituximab product for previously treated #follicularlymphoma and previously treated #marginalzonelymphoma: https://t.co/9OCu4z3O5g #lymsm #lymphoma #bloodcancer
Last Seen Hashtags on Sotwe
男尊女卑
Seen from United States
TEENAGER filter:videos
Seen from Australia
momson #momson filter:native_video
Seen from United Kingdom
pyrospy
Seen from Peru
YarenYapıcı
ديوت_بدوي
Seen from United Arab Emirates
Ometvcrot
Seen from Netherlands
BrasilRural
Seen from United States
หีน้ำแตก
Seen from Thailand
معصيتّيَ_رِحّتِي
Seen from Germany
Most Popular Users
Elon Musk 
@elonmusk
241.1M followers
Barack Obama
@barackobama
119.1M followers
Cristiano Ronaldo
@cristiano
112.3M followers
Donald J. Trump
@realdonaldtrump
111.8M followers
Narendra Modi
@narendramodi
107.1M followers
Rihanna
@rihanna
98.1M followers
NASA
@nasa
92.2M followers
Justin Bieber
@justinbieber
91.3M followers
KATY PERRY
@katyperry
88.6M followers
Taylor Swift
@taylorswift13
82.5M followers
Lady Gaga
@ladygaga
74M followers
Virat Kohli
@imvkohli
71.4M followers
Kim Kardashian
@kimkardashian
70.3M followers
YouTube
@youtube
68.7M followers
Bill Gates
@billgates
64.4M followers
Neymar Jr
@neymarjr
64.3M followers
The Ellen Show
@theellenshow
62.4M followers
CNN
@cnn
61.8M followers
Selena Gomez
@selenagomez
61.7M followers
X
@x
60.8M followers